Furthermore, it has been reported that the inhibition of the Akt/mTOR pathway and NF-κB can enhance the effects of anti-cancer drugs and radiation and suppresses tumor angiogenesis in osteosarcoma cells (70). Here, NFKB1 is linked to osteosarcoma.